Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.50 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL842761 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL2679607 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL2679170 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL991008 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL57744 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL2679806 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL991604 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL991234 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL2679382 | 1.00 | LMNA (0.58) | LMNAMAPTMEN1NR1I2CHRM2 | |
| SCHEMBL843196 | 0.98 | MAPT (0.56) | LMNAMAPTMEN1NR1I2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022059590-A1 | LIGHT- OR HEAT-RESPONSIVE CLEAVAGE MOLECULAR LAYER | 国立研究開発法人産業技術総合研究所 | 2022-03-24 | — | — | WO | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-2485289-B1 | LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-2605621-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD OF PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-2846374-B1 | Layered structure | SUMITOMO CHEMICAL CO (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-2692796-B1 | COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2019-07-10 | — | — | EP | disclosed |
| EP-2597933-B1 | MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2019-06-12 | — | — | EP | disclosed |
| EP-2518111-B1 | COMPOSITION AND LUMINESCENT ELEMENT OBTAINED USING SAME | SUMITOMO CHEMICAL CO (JP) | 2019-03-13 | — | — | EP | disclosed |
| US-9929369-B2 | Organic electroluminescent element and method for manufacturing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-27 | — | — | US | disclosed |
| EP-2067805-A1 | POLYMER COMPOUND AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2009-06-10 | — | — | EP | disclosed |
| EP-2048176-A1 | POLYMER COMPOUND AND POLYMER LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-20080248220-A1 | Light-Emitting Material and Light-Emitting Device Using the Same | SUMITOMO CHEMICAL COMPANY,LIMITED | 2008-10-09 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-7208567-B2 | Polymer compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-24 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| US-20040002576-A1 | Polymer compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-01-01 | — | — | US | disclosed |
| EP-1344788-A1 | Conjugated polymer comprising dibenzothiophene- or dibenzofuran-units and their use in polymer LEDs | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | LMNA 4594/4885MAPT 4299/4885MEN1 4525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.